======= EIF2B4 ======= == Gene Information == * **Official Symbol**: EIF2B4 * **Official Name**: eukaryotic translation initiation factor 2B subunit delta * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8890|8890]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UI10|Q9UI10]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EIF2B4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EIF2B4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606687|Open OMIM]] == Function Summary == * **Entrez Summary**: Eukaryotic initiation factor 2B (EIF2B), which is necessary for protein synthesis, is a GTP exchange factor composed of five different subunits. The protein encoded by this gene is the fourth, or delta, subunit. Defects in this gene are a cause of leukoencephalopathy with vanishing white matter (VWM) and ovarioleukodystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP. |IF-2B| |eukaryotic translation initiation factor 2B complex| |translation initiation factor binding| |oligodendrocyte development| |ovarian follicle development| |translation initiation factor activity| |oligodendrocyte differentiation| |female gonad development| |development of primary female sexual characteristics| |guanyl-nucleotide exchange factor activity| |myelination| |glial cell development| |female sex differentiation| |ensheathment of neurons| |axon ensheathment| |response to heat| |response to glucose| |translational initiation| |response to hexose| |response to monosaccharide| |glial cell differentiation| |response to carbohydrate| |T cell receptor signaling pathway| |response to temperature stimulus| |gonad development| |gliogenesis| |development of primary sexual characteristics| |sex differentiation| |antigen receptor-mediated signaling pathway| |regulation of translation| |translation| |response to peptide hormone| |regulation of cellular amide metabolic process| |peptide biosynthetic process| |reproductive structure development| |reproductive system development| |immune response-activating cell surface receptor signaling pathway| |response to peptide| |immune response-regulating cell surface receptor signaling pathway| |posttranscriptional regulation of gene expression| |amide biosynthetic process| |peptide metabolic process| |immune response-activating signal transduction| |immune response-regulating signaling pathway| |activation of immune response| |developmental process involved in reproduction| |cellular amide metabolic process| |positive regulation of immune response| |response to hormone| |central nervous system development| |response to organonitrogen compound| |response to nitrogen compound| |positive regulation of immune system process| |regulation of immune response| |response to abiotic stimulus| |organonitrogen compound biosynthetic process| |reproductive process| |reproduction| |response to endogenous stimulus| |response to oxygen-containing compound| |neurogenesis| |cellular nitrogen compound biosynthetic process| |cell development| |regulation of immune system process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp116|AICAR 240μM R03 exp116]]|-1.78| |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|1.7| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|1.71| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|1.72| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|1.74| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.76| |[[:results:exp376|Losmapimod 1μM R07 exp376]]|1.78| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|1.83| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|1.83| |[[:results:exp302|35°C R06 exp302]]|1.86| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.91| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|2.12| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|2.18| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|2.3| ^Gene^Correlation^ |[[:human genes:p:ppp1r15b|PPP1R15B]]|0.477| |[[:human genes:e:eif2b5|EIF2B5]]|0.415| |[[:human genes:d:dnajc16|DNAJC16]]|0.412| Global Fraction of Cell Lines Where Essential: 297/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|8/28| |blood|11/28| |bone|9/26| |breast|12/33| |central nervous system|24/56| |cervix|1/4| |colorectal|9/17| |esophagus|6/13| |fibroblast|0/1| |gastric|10/16| |kidney|12/21| |liver|6/20| |lung|29/75| |lymphocyte|11/16| |ovary|10/26| |pancreas|6/24| |peripheral nervous system|9/16| |plasma cell|6/15| |prostate|1/1| |skin|4/24| |soft tissue|5/9| |thyroid|1/2| |upper aerodigestive|7/22| |urinary tract|12/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 700 * **Expression level (log2 read counts)**: 5.98 {{:chemogenomics:nalm6 dist.png?nolink |}}